Skip to content

Person-checked company records fromPerson-checked records $750See a worked exampleHuman review in progress

Talk to sales

KeptIndex

Beam Therapeutics Inc.

Enroll first subject for BEAM-101 trial

Delivered by the deadline

AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.

Announced
10 Jan 2022
Due
31 Dec 2022
Delivered
November 2022
  • Deadline
  • Met
  • Late
  • Not met
  • Today

What the company said

“First subject enrolled for BEAM-101 in 2H 2022”

What we found

Evidence strength A What the grades mean

Beam Therapeutics announced in November 2022 that they had enrolled the first patient in the BEACON clinical trial for BEAM-101, meeting their commitment to do so within the second half of 2022.

  • A
    Beam Therapeutics Inc. 10-K filed 2023-02-28 Regulatory filing · published 28 Feb 2023 · retrieved 2 Oct 2026 · kept permanently by the SEC
    “In November 2022, we announced that we enrolled the first patient in our Phase 1/2 clinical trial designed to assess the safety and efficacy of BEAM-101” ✓ confirmed on the page

Market reaction: the shares moved -0.5% against the S&P 500 over the three sessions around the disclosure (27 Feb 2023 to 2 Mar 2023). What this measures

Checked 2 Oct 2026.

Commitment DNA

The structured record of this commitment. Fields the company did not state are left blank rather than guessed.

Event type
Clinical milestone
Indicative materiality
Medium rules
Action
Enroll
Deliverable
First subject enrolled for BEAM-101
In the company’s control
Medium
Specificity
High
Depends on
Customer

How this entry was checked

  1. Commitment recordedThe company's words were matched word for word against the filing.
  2. First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
  3. Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.

Confirmed. This outcome counts towards the company's Kept Score. How verification works

Are you Beam Therapeutics Inc.? You can publish an official statement next to this entry, free. Add a statement.

Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.

Report an error in this entry Reference: KI-C-2022-BEAM-003196 · Corrections policy

The Deadline Report

One email a week: the corporate commitments that came due, which were met, which slipped, and what is due next. Free. Stop any time.

No advertising. We never sell or share your address.